Todd Levine

3.7k total citations
75 papers, 1.5k citations indexed

About

Todd Levine is a scholar working on Neurology, Epidemiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Todd Levine has authored 75 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Neurology, 17 papers in Epidemiology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Todd Levine's work include Peripheral Neuropathies and Disorders (21 papers), Inflammatory Myopathies and Dermatomyositis (15 papers) and Hereditary Neurological Disorders (12 papers). Todd Levine is often cited by papers focused on Peripheral Neuropathies and Disorders (21 papers), Inflammatory Myopathies and Dermatomyositis (15 papers) and Hereditary Neurological Disorders (12 papers). Todd Levine collaborates with scholars based in United States, Germany and Czechia. Todd Levine's co-authors include Alan Pestronk, David Saperstein, Brian K. Lang, David J. Berg, Lucy G. Andrews, Peter H. King, Jack D. Keene, Nicole Hank, Robert Bowser and Thomas L. Anderson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular and Cellular Biology and Neurology.

In The Last Decade

Todd Levine

68 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Todd Levine United States 21 504 369 266 263 239 75 1.5k
Sung‐Min Kim South Korea 25 552 1.1× 95 0.3× 384 1.4× 242 0.9× 139 0.6× 94 1.7k
Keiichi Sakai Japan 18 242 0.5× 230 0.6× 373 1.4× 53 0.2× 203 0.8× 117 1.3k
Christopher A. Robinson Canada 20 643 1.3× 97 0.3× 171 0.6× 70 0.3× 119 0.5× 34 1.3k
Tsuyoshi Tada Japan 24 692 1.4× 350 0.9× 396 1.5× 82 0.3× 225 0.9× 101 1.8k
Nina Iversen Norway 24 262 0.5× 112 0.3× 422 1.6× 31 0.1× 124 0.5× 78 1.7k
Heather A. Arnett United States 22 99 0.2× 157 0.4× 1.1k 4.0× 175 0.7× 151 0.6× 36 3.7k
Zhilong Jiang China 21 458 0.9× 152 0.4× 490 1.8× 38 0.1× 50 0.2× 63 1.7k
Zhiyong Zhao China 30 109 0.2× 233 0.6× 1.3k 5.1× 164 0.6× 94 0.4× 98 2.6k
Roberto Mendoza‐Londono Canada 26 126 0.3× 124 0.3× 1.0k 3.8× 258 1.0× 108 0.5× 85 2.1k
Marı́a José Blanco Spain 24 143 0.3× 138 0.4× 3.2k 12.1× 85 0.3× 127 0.5× 55 4.9k

Countries citing papers authored by Todd Levine

Since Specialization
Citations

This map shows the geographic impact of Todd Levine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Levine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Levine more than expected).

Fields of papers citing papers by Todd Levine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd Levine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Levine. The network helps show where Todd Levine may publish in the future.

Co-authorship network of co-authors of Todd Levine

This figure shows the co-authorship network connecting the top 25 collaborators of Todd Levine. A scholar is included among the top collaborators of Todd Levine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd Levine. Todd Levine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aggarwal, Rohit, Joachim Schessl, Zsuzsanna Bata‐Csörgõ, et al.. (2025). Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study. Rheumatology and Therapy. 12(5). 855–871.
2.
Freimer, Miriam, Raghav Govindarajan, Shaida Khan, et al.. (2025). Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label study. Therapeutic Advances in Neurological Disorders. 18. 4243628371–4243628371. 1 indexed citations
3.
Gibbons, Christopher H., et al.. (2024). A Novel Diagnostic Method for Detection and Quantitation of Cutaneous Phosphorylated Alpha-synuclein (S26.004). Neurology. 102(7_supplement_1). 1 indexed citations
4.
Barohn, Richard J., Mazen M. Dimachkie, Todd Levine, David Saperstein, & Jonathan Katz. (2024). Pattern Recognition of Neuropathy and Neuronopathy. Macedonian Journal of Medical Sciences (University of Skopje). 5(1).
5.
Pasnoor, Mamatha, Vera Bril, Todd Levine, et al.. (2023). Phase 2 trial in acetylcholine receptor antibody‐positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study. European Journal of Neurology. 30(5). 1417–1424. 2 indexed citations
6.
Werth, Victoria P., Rohit Aggarwal, Christina Charles‐Schoeman, et al.. (2023). Efficacy of intravenous immunoglobulins (IVIg) in improving skin symptoms in patients with dermatomyositis: a post-hoc analysis of the ProDERM study. EClinicalMedicine. 64. 102234–102234. 7 indexed citations
7.
Nowak, Richard J., Ari Breiner, Vera Bril, et al.. (2023). Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open‐label extension. Annals of Clinical and Translational Neurology. 11(1). 194–206. 11 indexed citations
8.
Bhai, Salman, Robert Bowser, Suzan A. Moser, et al.. (2023). A 40-week Phase 2B Randomized, Multicenter, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Memantine in Amyotrophic Lateral Sclerosis (P8-8.011). Neurology. 100(17_supplement_2). 1 indexed citations
9.
10.
Dimachkie, Mazen M., Vera Bril, Todd Levine, et al.. (2019). Subcutaneous Immunoglobulin in Myasthenia Gravis: Results of a North American Open Label Study (N4.002). Neurology. 92(15_supplement). 5 indexed citations
11.
Levine, Todd. (2018). Small Fiber Neuropathy: Disease Classification Beyond Pain and Burning. SHILAP Revista de lepidopterología. 10. 3700598263–3700598263. 46 indexed citations
12.
Levine, Todd, David Saperstein, Alan Pestronk, & Jack W. Kent. (2017). Identification of a Novel Immune Mediated Cause for Small Fiber Neuropathy (P4.137). Neurology. 88(16_supplement). 4 indexed citations
13.
Rodríguez‐Leyva, Ildefonso, Érika Chi-Ahumada, William Eng, et al.. (2017). The Presence of Alpha‐Synuclein in Skin from Melanoma and Patients with Parkinson's Disease. Movement Disorders Clinical Practice. 4(5). 724–732. 29 indexed citations
14.
Saperstein, David & Todd Levine. (2016). Interim Analysis of a Pilot Trial of Natalizumab in Inclusion Body Myositis (P3.161). Neurology. 86(16_supplement). 7 indexed citations
15.
Levine, Todd & David Saperstein. (2014). Routine use of punch biopsy to diagnose small fiber neuropathy in fibromyalgia patients. Clinical Rheumatology. 34(3). 413–417. 37 indexed citations
16.
Levine, Todd, David Saperstein, Nicole Hank, et al.. (2013). ADAPT: Acthar in Dermatomyositis and Polymyositis Treatment Registry (P07.041). Neurology. 80(7_supplement). 1 indexed citations
17.
Levine, Todd & David Saperstein. (2013). Laboratory Evaluation of Peripheral Neuropathy. Neurologic Clinics. 31(2). 363–376. 8 indexed citations
18.
Levine, Todd, et al.. (2011). Clinical Recognition and Management of Amyotrophic Lateral Sclerosis. Journal of Neuroscience Nursing. 43(4). 205–214. 6 indexed citations
19.
Berg, David J., Todd Levine, James A. Stoeckel, & Brian K. Lang. (2008). A conceptual model linking demography and population genetics of freshwater mussels. Journal of the North American Benthological Society. 27(2). 395–408. 22 indexed citations
20.
Levine, Todd. (2003). History of Dermatomyositis. Archives of Neurology. 60(5). 780–780. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sung‐Min Kim Breakdown of academic impact, for papers by Keiichi Sakai Breakdown of academic impact, for papers by Christopher A. Robinson Breakdown of academic impact, for papers by Tsuyoshi Tada Breakdown of academic impact, for papers by Nina Iversen Breakdown of academic impact, for papers by Heather A. Arnett Breakdown of academic impact, for papers by Zhilong Jiang Breakdown of academic impact, for papers by Zhiyong Zhao Breakdown of academic impact, for papers by Roberto Mendoza‐Londono Breakdown of academic impact, for papers by Marı́a José Blanco
Rankless by CCL
2026